Therapeutic Asset Ratings

9,928 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Chronic Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	CC (43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Myelodysplastic Syndrome	Fred Hutchinson Cancer Center	P1	CC (43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Acute Lymphoblastic Leukemia	Fred Hutchinson Cancer Center	P1	CC (43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Adult Acute Lymphoblastic Leukemia	Fred Hutchinson Cancer Center	P1	CC (43)
Cdk-003 Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	Codiak BioSciences	P1	CC (43)
Cdk-004 Metastasis From Malignant Tumor Of Colon	Codiak BioSciences	P1	CC (43)
Cdk-004 Gastric Cancer	Codiak BioSciences	P1	CC (43)
Cdx 1140 Basal Cell Carcinoma	University of Southern California	P1	CC (43)
Cdx 1140 Bone Sarcoma	University of Southern California	P1	CC (43)
Cea Car-T Cells Metastatic Neoplasm	Chongqing Precision Biotech Co., Ltd	P1	CC (43)
Cea Car-T Cells Cancer	Chongqing Precision Biotech Co., Ltd	P1	CC (43)
Cea-Targeted Car-T Bile Duct Cancer	Chongqing Precision Biotech Co., Ltd	P1	CC (43)
Cea-Targeted Car-T Peritoneal Carcinomatosis	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Cedazuridine Breast Cancer	National Cancer Institute (NCI)	P1	CC (43)
Cedazuridine Disease Related To Hematopoietic Stem Cell Transplant	Jacqueline Garcia, MD	P1	CC (43)
Cedazuridine Myelodysplastic/Myeloproliferative Neoplasm	Jacqueline Garcia, MD	P1	CC (43)
Cedazuridine B-Cell Non-Hodgkin Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Cedazuridine Hodgkins Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Cedazuridine Peripheral T-Cell Lymphoma, Not Otherwise Specified	Taiho Oncology, Inc.	P1	CC (43)
Cedazuridine Prostate Cancer	Roswell Park Cancer Institute	P1	CC (43)
Cefazolin Cutaneous Melanoma	M.D. Anderson Cancer Center	P1	CC (43)
Cemsidomide Non-Hodgkin Lymphoma	C4 Therapeutics, Inc.	P1	CC (43)
Cenegermin-Bkbj Corneal Disorder	Tufts Medical Center	P1	CC (43)
Cenegermin-Bkbj Peripheral Neuropathy	Tufts Medical Center	P1	CC (43)
Ceralasertib Colon Adenocarcinoma	National Cancer Institute (NCI)	P1	CC (43)

Showing 1576 to 1600 of 9,928 assets

PreviousPage 64 of 398Next